-
Mashup Score: 7
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 48Prasad Co-Author 2024 Publications - Google Drive - 13 hour(s) ago
Bardosh K, Krug A, Jamrozik E, Lemmens T, Keshavjee S, Prasad V, Makary MA, Baral S, Høeg TB. COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities. J Med Ethics. January 2024..pdf Barosa M, Jamrozik E, Prasad V. The Ethical Obligation for Research During Public Health Emergencies: Insights From the COVID-19 Pandemic. Med Health Care Philos. March 2024. .pdf Benjamin DJ, Haslam A, Prasad V. Cardiovascular/anti-inflammatory drugs
Source: drive.google.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 7Dual Checkpoint Inhibition in Melanoma With ≥1% PD-L1—Time to Reassess the Evidence - 17 hour(s) ago
This Viewpoint discusses use of anti–PD-1 monotherapy as the primary treatment option for patients with treatment-naive metastatic melanoma staining positive for PD-L1 over dual checkpoint inhibition therapy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Dual Checkpoint Inhibition in Melanoma With ≥1% PD-L1—Time to Reassess the Evidence - 19 hour(s) ago
This Viewpoint discusses use of anti–PD-1 monotherapy as the primary treatment option for patients with treatment-naive metastatic melanoma staining positive for PD-L1 over dual checkpoint inhibition therapy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Dual Checkpoint Inhibition in Melanoma With ≥1% PD-L1—Time to Reassess the Evidence - 19 hour(s) ago
This Viewpoint discusses use of anti–PD-1 monotherapy as the primary treatment option for patients with treatment-naive metastatic melanoma staining positive for PD-L1 over dual checkpoint inhibition therapy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 125COVID 19 recap - I am interviewed about COVID19 errors, particularly those made by government - 2 day(s) ago
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4COVID 19 recap - I am interviewed about COVID19 errors, particularly those made by government - 2 day(s) ago
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 125COVID 19 recap - I am interviewed about COVID19 errors, particularly those made by government - 2 day(s) ago
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18What to expect from the LAURA trial presentation at ASCO-2024? (a PFS benefit? take it for granted) - 2 day(s) ago
Osimertinib “maintenance” after chemoradiotherapy in EGFR-mutated unresectable stage III lung cancer.
Source: www.drugdevletter.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 21Stanford's Censorship: Rescind the Disgraceful Atlas Censure - 3 day(s) ago
If Stanford is to remain a true academic institution, it must reverse its shameful Covid-era censure of Dr. Scott Atlas.
Source: stanfordreview.orgCategories: General Medicine News, Expert PicksTweet
Also on youtube if you prefer that https://t.co/RrfKTj4fzl